Accelerate Investment Advisors’s AbbVie ABBV Stock Holding History

Accelerate Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$432K	Sell	1,717 -47	-3%	-$10.1K	0.25%	69
2026 Q1	$384K	Sell	1,764 -225	-11%	-$49.9K	0.26%	58
2025 Q4	$454K	Buy	1,989 +204	+11%	+$46.5K	0.31%	48
2025 Q3	$413K	Buy	1,785 +3	+0.2%	+$611	0.28%	55
2025 Q2	$331K	Buy	1,782 +628	+54%	+$117K	0.25%	66
2025 Q1	$242K	Sell	1,154 -83	-7%	-$16.1K	0.2%	84
2024 Q4	$220K	Buy	1,237 +127	+11%	+$23.4K	0.19%	87
2024 Q3	$219K	Buy	+1,110	New	+$207K	0.21%	74

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Accelerate Investment Advisors's ABBV Position: Q2 2026 in Review

Accelerate Investment Advisors reduced its AbbVie (ABBV) stake by 2.7% in Q2 2026, selling an estimated $10.1K and leaving 1,717 shares worth $432K. The position accounts for 0.25% of the portfolio, ranked #69.

Accelerate Investment Advisors first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. The position peaked at $454K in Q4 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Accelerate Investment Advisors held 1,717 shares of AbbVie worth $432K as of Q2 2026.
Accelerate Investment Advisors sold 47 AbbVie shares in Q2 2026, an estimated $10.1K.
AbbVie made up 0.25% of Accelerate Investment Advisors's portfolio in Q2 2026, its #69 holding.
Accelerate Investment Advisors first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
Accelerate Investment Advisors's AbbVie position peaked at $454K in Q4 2025.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Accelerate Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.